Akihiro Tsujimura
Vorstandsvorsitzender bei MITSUBISHI TANABE PHARMA CORPORATION
Aktive Positionen von Akihiro Tsujimura
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| MITSUBISHI TANABE PHARMA CORPORATION | Vorstandsvorsitzender | - | - |
SanBio, Inc.
 SanBio, Inc. Medical/Nursing ServicesHealth Services SanBio, Inc. develops regenerative therapies for neurological disorders. The firm is focused on cell therapies for neurological disorders such as stroke, traumatic brain injury, eye disease, and Parkinson's disease. Its product pipeline includes SB623 and SB618. The company was founded by Keita Mori and Toru Kawanishi in 2001 and is headquartered in Mountain View, CA. | Direktor/Vorstandsmitglied | 01.10.2018 | - |
| Vorstandsvorsitzender | 01.10.2018 | - |
Karriereverlauf von Akihiro Tsujimura
Ehemalige bekannte Positionen von Akihiro Tsujimura
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Santen, Inc.
 Santen, Inc. Medical SpecialtiesHealth Technology Part of Santen Pharmaceutical Co., Ltd., Santen, Inc. is a company that develops ophthalmic products. The company is based in Emeryville, CA. The company was founded in 1993 by Adrienne L. Graves. Tatsuya Kaihara has been the CEO of the company since 2017. | Vorstandsvorsitzender | 03.04.2012 | 01.10.2018 |
| Präsident | 03.04.2012 | 01.10.2018 | |
| SANBIO COMPANY LIMITED | Direktor/Vorstandsmitglied | 26.04.2019 | - |
| Geschäftsführer | - | - | |
| Corporate Officer/Principal | 01.10.2018 | - | |
| SANTEN PHARMACEUTICAL CO., LTD. | Direktor/Vorstandsmitglied | 23.06.2017 | - |
| Corporate Officer/Principal | 20.07.2011 | - |
Ausbildung von Akihiro Tsujimura
| Kanazawa University | Undergraduate Degree |
| Kobe University | Masters Business Admin |
Statistik
International
| Japan | 6 |
| Vereinigte Staaten | 3 |
Operativ
| Director/Board Member | 3 |
| Chief Executive Officer | 3 |
| Corporate Officer/Principal | 2 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 3 |
| Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| SANTEN PHARMACEUTICAL CO., LTD. | Health Technology |
| SANBIO COMPANY LIMITED | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Santen, Inc.
Santen, Inc. Medical SpecialtiesHealth Technology Part of Santen Pharmaceutical Co., Ltd., Santen, Inc. is a company that develops ophthalmic products. The company is based in Emeryville, CA. The company was founded in 1993 by Adrienne L. Graves. Tatsuya Kaihara has been the CEO of the company since 2017. | Health Technology |
SanBio, Inc.
SanBio, Inc. Medical/Nursing ServicesHealth Services SanBio, Inc. develops regenerative therapies for neurological disorders. The firm is focused on cell therapies for neurological disorders such as stroke, traumatic brain injury, eye disease, and Parkinson's disease. Its product pipeline includes SB623 and SB618. The company was founded by Keita Mori and Toru Kawanishi in 2001 and is headquartered in Mountain View, CA. | Health Services |
Mitsubishi Tanabe Pharma Corp.
 Mitsubishi Tanabe Pharma Corp. Pharmaceuticals: OtherHealth Technology Mitsubishi Tanabe Pharma Corp. engages in the research, development, manufacture, and sale of pharmaceutical products. Its products include Remicade, Ceredist, Talion, Kremezin, Maintate, Simponi, Lexapro, Tenelia, Tetrabik, and Imusera. The company was founded by Gohei Tanabeya in 1678 and is headquartered in Osaka, Japan. | Health Technology |
- Börse
- Insiders
- Akihiro Tsujimura
- Erfahrung
